← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Research Institute At Nationwide Children'S Hospital
$20,207,526
Total funding
25
Grants
Funding over time
peak $5.8M · FY2008–25$10M$7.5M$5M$2.5M$0
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
DOD$19,513,882 · 23
DOE$693,644 · 2
By mechanism
—$20,207,526 · 25
Investigators at Research Institute At Nationwide Children'S Hospital
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Not enough data
Largest grants
COMPARISON OF THE LONG-TERM EFFICACY OF TISSUE-ENGINEERED VASCULAR GRAFTS VERSUS POLYTETRAFLUOROETHYLENE CONDUITS USING AN ESTABLISHED PRECLINICAL MODEL$4,273,376
· FY2022 · Defense Health Agency
DEVELOPMENT AND PRECLINICAL VALIDATION OF AN IMPROVED TISSUE ENGINEERED VASCULAR GRAFT FOR USE IN CONGENITAL HEART SURGERY$4,049,040
· FY2018 · Defense Health Agency
IDENTIFICATION AND CIRCUMVENTION OF RESISTANCE AFTER DONOR-DERIVED EX VIVO EXPANDED NK CELLS AND HAPLO-HCT IN CHILDREN AND YOUNG ADULTS WITH HIGH-RISK AML$1,339,955
· FY2025 · Defense Health Agency
TRANSLATIONAL STUDIES OF GALGT2 GENE THERAPY FOR DUCHENNE MUSCULAR DYSTROPHY$921,400
· FY2012 · Department of the Army
DEVELOPING NEW THERAPEUTIC STRATEGIES FOR MALIGNANT$864,974
· FY2018 · Defense Health Agency
CLINICAL UTILITY AND PITFALLS OF ULTRASOUND GUIDED FOREIGN BODY REMOVAL IN WAR FIGHTERS$849,452
· FY2008 · Department of Defense
INTEGRATIVE LIFECOURSE AND GENETIC ANALYSIS OF MILITARY WORKING DOGS$849,115
· FY2011 · Department of Defense
SHIFTING IMMUNE BALANCE TO EXTEND ONCOLYTIC VIRUS RESPONSE IN MALIGNANT PERIPHERAL NERVE SHEATH TUMORS. NEW AWARD.$816,483
· FY2020 · Defense Health Agency
BRIGATINIB AND ITS COMBINATION WITH INK-128 AS A NOVEL TREATMENT FOR NF2-DEFICIENT MENINGIOMAS$705,578
· FY2018 · Defense Health Agency
PRECLINICAL DEVELOPMENT OF MICRO-TUBERIN GENE THERAPY FOR TUBEROUS SCLEROSIS COMPLEX TYPE 2$703,000
· FY2025 · Defense Health Agency
NEW; TITLE: NATIONAL REPOSITORY FOR CHILDRENS AND WOMENS CANCER; PI: NILSA RAMIREZ$693,644
· FY2009 · Department of Energy
COMPREHENSIVE IN VIVO PHENOTYPING OF FUSION-DRIVEN PEDIATRIC RHABDOMYOSARCOMAS$624,000
· FY2025 · Defense Health Agency
SPLICING UP PD-L1 FOR IMMUNOTHERAPY ENHANCEMENT IN PEDIATRIC NEURONAL TUMORS$624,000
· FY2025 · Defense Health Agency
BITE GENE THERAPY TO AUGMENT ONCOLYTIC VIROTHERAPY$599,730
· FY2019 · Defense Health Agency
NOVEL PROBIOTIC RIDE SHARE TECHNOLOGY FOR THE IMPROVEMENT OF BRAIN-GUT MICROBIOME INTERACTIONS$549,940
· FY2025 · Defense Health Agency
OVERCOMING IMMUNE ESCAPE MECHANISMS IN IMMUNOTHERAPY OF NEUROBLASTOMA$338,625
· FY2017 · Department of the Army
NOVEL PROBIOTIC RIDE SHARE TECHNOLOGY FOR THE IMPROVEMENT OF BRAIN-GUT MICROBIOME INTERACTIONS$307,892
· FY2025 · Defense Health Agency
DISSECTING MECHANISMS UNDERLYING BRAIN CALCIFICATION IN TSC$231,000
· FY2021 · Department of the Army
VALIDATION OF FUNCTIONAL REACHING VOLUME AS AN OUTCOME MEASURE ACROSS THE SPECTRUM OF ABILITIES IN MUSCULAR DYSTROPHY$202,736
· FY2016 · Department of Defense
CLINICAL UTILITIES AND PITFALLS OF ULTRASOUND GUIDED FOREIGN BODY REMOVAL***$166,396
· FY2015 · Department of the Army